Delivery Order SPE2DB22D3301-SPE2DB25FX4SK

Award Date 10/30/24
Potential Completion Date 10/31/24
Potential Value $5.1K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $5,369.09 firm fixed-price delivery order is for the supply of NUCYNTA 100 MG TABLET 100S, a pharmaceutical product. The award is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 between Amerisourcebergen and the DLA Troop Support Medical, which serves as a primary vehicle for providing a...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,195.86 delivery order contract is for the supply of NUCYNTA 50 MG TABLET 100S, a prescription medication. The award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical. This IDC serves as a primary vehicle for...
This federal contract award was made by the Defense Logistics Agency (DLA), a defense agency of the U.S. Department of Defense, to Amerisourcebergen Drug Corp's Corporate Office Division. The $1,155.92 firm fixed-price delivery order is for the supply of NUCYNTA 50 MG TABLET 100S, a pharmaceutical product. The award is associated with a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, valued at up to $999,999,999.00 through December 31,...
This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,702.32 firm-fixed-price delivery order is for the supply of NUCYNTA 75 MG tablets. The contract has an ultimate completion date of March 5, 2025. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for...
This federal contract award is for the delivery of Nucynta medication tablets (50mg) to the Defense Logistics Agency (DLA) Troop Support Medical. The $22,501.48 firm fixed-price delivery order was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary vehicle for the company to supply a comprehensive range...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,879.70 firm fixed-price delivery order is for the supply of NUCYNTA 50 MG TABLET 100S, a pharmaceutical product. The contract has an ultimate completion date of March 3, 2025. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical through...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,986.28 firm-fixed-price delivery order is for the supply of NUCYNTA 75 MG TABLET 100S, a medication, to support military healthcare programs. The award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, which serves as a primary...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,194.33 firm fixed-price delivery order is for the supply of NUCYNTA ER 50 MG TABLET 60S, a pharmaceutical product. The contract has an ultimate completion date of January 13, 2025. The award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,225.04 firm fixed-price delivery order is for the supply of NUCYNTA 50 MG TABLET 100S, with a completion date of February 26, 2025. The contract is not designated as a set-aside award. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, was issued by the Defense Logistics Agency (DLA) Troop Support Medical. The $5,970.19 firm fixed-price delivery order provides the DLA with NUCYNTA TABS 50MG, a pharmaceutical product, to support military healthcare programs. The contract has an ultimate completion date of February 19, 2025 and was awarded on February 18, 2025. This contract is part of a larger $999,999,999 Indefinite Delivery...
  • SPE2DB22D3301
    Indefinite Delivery Contract
  • SPE2DB22D3301-SPE2DB25FX4SK
    Delivery Order

This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $5,134.86 firm fixed-price delivery order is for the supply of NUCYNTA 50 MG tablets to support various federal healthcare programs.

The award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to military healthcare programs globally. This IDC covers critical medical commodities across multiple therapeutic areas, including specialty medications, brand-name and generic drugs, vaccines, syringes, vials, and test kits.

The contract award does not have a set-aside designation, indicating open competition. No subcontractor information is provided. This contract supports the DLA's mission of providing logistics, acquisition, and technical services to the U.S. military and other federal agencies.

Generated 1/29/25, 9:20 AM